Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices | Market Insights | Asia Pacific | 2024

The Asia Pacific GI endoscopy device market was negatively impacted by the COVID-19 pandemic. Following recovery, the market will grow moderately throughout the forecast period, mainly due to the efficiency of nationwide CRC and GI cancer screening programs, especially in Australia and South Korea, the high incidence of gastric cancer and CRC cases in the region, the increasing uptake of GI endoscopy devices among physicians due to training programs and conferences, and the improving healthcare infrastructure, especially in China and India. However, ASP declines due to price-based competition will continue to hamper some segments within the Asia Pacific GI endoscopy devices market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for GI endoscopy devices in Asia Pacific from 2019 through 2032.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…
Report
Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2025
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…